Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma

Journal of Molecular Neuroscience

Volumn 47, Issue 3, 2012, Pages 442-447

  Zhou, You Xin ^a   Wang, Jun Xiang ^b   Feng, Ming ^a   Sun, Chun Ming ^a   Sun, Ting ^a   Chen, Gui Lin ^a   Du, Zi Wei ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Department of Neurosurgery   (China)

Author keywords

Glioma; Immunohistochemistry; Isocitrate dehydrogenase (IDH) 1; Western blot

Indexed keywords

B RAF KINASE; ISOCITRATE DEHYDROGENASE 1;

ARTICLE; ASTROCYTOMA; EPENDYMOMA; GENE EXPRESSION; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MEDULLOBLASTOMA; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; EPENDYMOMA; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; ISOCITRATE DEHYDROGENASE; MALE; MEDULLOBLASTOMA; MIDDLE AGED; OLIGODENDROGLIOMA; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84863874960     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9681-5     Document Type: Article

References (16)

1. Aghili M, Zahedi F, Rafiee E (2009) Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J Neurooncol 91(2):233-236
2. DeBerardinis R, Lum J, Hatzivassiliou G, Thompson B (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7(1):11-20
3. Forshew T, Tatevossian RG, Lawson AR (2009) Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 218(2):172-181
4. Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP (2000) Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 60(2):417-424 (Pubitemid 30070771)
5. Kang MR, Kim MS, Oh JE et al (2009) Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 125(2):353-355
6. Kil IS, Kim SY, Lee SJ, Park JW (2007) Small interfering RNA-mediated silencing of mitochondrial NADP+-dependent isocitrate dehydrogenase enhances the sensitivity of HeLa cells toward tumor necrosis factor-alpha and anticancer drugs. Free Radic Biol Med 43(8):1197-1207 (Pubitemid 47374439)
7. +-dependent isocitrate dehydrogenase. Mol Cell Biochem 302(1-2):27-34
8. Lee SM, Koh HJ, Park DC, Song BJ, Huh TL, Park JW (2002) Cytosolic NADP (+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 32 (11):1186-1186
9. Louis D, Ohgaki H, Wiesler O, Cavenee W (2007) WHO classification of tumours of the central nervous system. International Agency for Research on Cancer (IARC), Lyon
10. Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479-489 (Pubitemid 40781150)
11. Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170(5):1445-1453 (Pubitemid 47339290)
12. Okamoto Y, Di Patre PL, Burkhard C et al (2004) Population-based study on incidence, survival rates, and genetic alterations of low-grade astrocytomas and oligodendrogliomas. Acta Neuropathol 108(1):49-56 (Pubitemid 38961073)
13. Parsons D, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897): 1807-1812
14. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174(4):1149-1153
15. Xu X, Zhao J, Xu Z et al (2004) Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. J Biol Chem 279(32): 33946-33957 (Pubitemid 39063045)
16. Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765-673